UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549

                          FORM 10-QSB

[X]  Quarterly Report under Section 13 or 15(d) of the Securities
Exchange Act of 1934 For the quarterly period ended September 30, 2002

[ ]  Transition report under Section 13 or 15(d) of the Exchange Act
For the transition period from        to
                               -------   --------


                     Commission File Number: 0-31547

                            DRGOODTEETH.COM
          ----------------------------------------------------
         (Exact name of Registrant as specified in its charter)


        Nevada                                     88-0451554
 ---------------------------                   -----------------
(State or other jurisdiction                   (I.R.S. Employer
of incorporation or organization               Identification No.)


280 Madison Ave., Ste. 1110-211
       New York, NY 10016      		     (212) 386-5695
--------------------------------      -----------------------------
(Address of principal executive       (Registrant's telephone number,
 offices)                              including area code)


                                None
  -----------------------------------------------------------------
  Former Name, Address and Fiscal Year, If Changed Since Last Report

Check whether the issuer: (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or
for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the
past 90 days.   Yes   X      No

The number of shares outstanding of the registrant's common stock as of
September 30, 2002 was 4,000,000.

Registrant's common stock is listed on the OTCBB under the symbol "DRGT".

Transitional Small Business Disclosure Format:  Yes     No X


                                1
<PAGE>


                 Part I - Financial Information

Item 1.  Financial Statements

The interim financial statements for DrGoodTeeth.Com (the Company)
included herein are unaudited but reflect, in management's opinion, all
adjustments, consisting only of normal recurring adjustments, that are
necessary for a fair presentation of the Company's financial position
and the results of its operations for the interim periods presented.
Because of the nature of the Company's business, the results of
operations for the nine months ended September 30, 2002 are not necessarily
indicative of the results that may be expected for the full fiscal year.
The financial statements included herein should be read in conjunction
with the financial statements and notes thereto included in the Form
10-KSB for the year ended December 31, 2001.
































                                 2


<PAGE>





                    REPORT OF INDEPENDENT ACCOUNTANT




To the Board of Directors
DrGoodTeeth.com
(a Nevada Corporation)


We have made a review of the balance sheet of DrGoodTeeth.Com as of
September 30, 2002, and the related statements of operations and cash
flows for the three and nine months period ended September 30, 2002
and 2001, in accordance with the standards established by the American
Institute of Certified Public Accountants. These financial statements
are the responsibility of the Company's management.

A review of interim financial information consists principally of
obtaining an understanding of the system for the preparation of
interim financial information, applying analytical review procedures
to financial data, and making inquiries of persons responsible for
financial and accounting matters.  It is substantially less in scope
than an audit in accordance with generally accepted auditing
standards, the objective of which is the expression of an opinion
regarding the financial statements taken as a whole.  Accordingly,
we do not express such an opinion.

Based on our review, we are not aware of any material modifications
that should be made to the financial statements referred
to above for them to be in conformity with generally accepted
accounting principles.

We have previously audited, in accordance with generally accepted
auditing standards, the balance sheet as of December 31, 2001 and
the related statements of operations, cash flows and changes in
common shareholders' equity (deficit) for the period then ended; and
in our report dated February 20, 2002, we expressed an qualified opinion
on those financial statements.  In our opinion, the information set
forth in the accompanying balance sheet as of September 30, 2002, is
fairly stated in all material respects in relation to the balance
sheet from which it has been derived.

                              /s/ Clyde Bailey P.C.

San Antonio, Texas
October 28, 2002



                                     3
<PAGE>


<TABLE><CAPTION>
                              DrGoodTeeth.Com
                     (A Development Stage Enterprise)
                              Balance Sheet
                         As of September 30, 2002

                                        September 30  December 31
                                           2002          2001
                                         --------     -----------
                                        (Unaudited)    (Audited)
                                        ----------     ---------
<S>		  		            <C>	  	 <C>

                                 A S S E T S
                                 -----------
Current Assets
--------------
 Cash in Banks                           $ 85,547      $ 88,868
			                 --------      ---------
    Total Current Assets                 $ 85,547      $ 88,868
			                 --------      ---------
    Total Assets		         $ 85,547      $ 88,868
			                 ========      =========

                            L I A B I L I T I E S
                            ---------------------
Current Liabilities
-------------------
  Accounts Payable                           -               -
                                         --------      --------
    Total Current Liabilities                -               -
                                         --------      --------
    Total Liabilities                        -               -

                   S T O C K H O L D E R S '  E Q U I T Y
  		   --------------------------------------
  Common Stock		                   4,000         4,000
    100,000,000 authorized
    shares, par value $.001
    4,000,000 shares issued
    and outstanding

  Additional Paid-in-Capital             101,000       101,000
  Accumulated Deficit                    (20,453)      (16,132)
                                        --------      --------
    Total Stockholders' Equity            84,547        88,868
                                        --------      --------
    Total Liabilities and
     Stockholders' Equity               $ 84,547      $ 88,868
                                        ========      ========
</TABLE>
               See accompanying notes to Financial Statements.

                                       4
<PAGE>


<TABLE><CAPTION>
                              DrGoodTeeth.Com
                     (A Development Stage Enterprise)
                         Statement of Operations
                                (Unaudited)

                                     Three Months Ended     Nine Months Ended  From Inception to
                                        September 30          September 30     September 30, 2002
                                   -----------------------  ------------------ ------------------
                                    2002         2001        2002         2001
                                   ----------  ----------- --------------------
<S>                                 <C>           <C>         <C>         <c>            <c>
Revenues:
---------
    Revenues                       $     -     $      -     $    -    $     -      $        -
                                  -----------  -----------  --------  ---------    ------------
    Total Revenues                       -            -          -          -               -

Expenses:
---------
  Professional Fees                      750          -        3,261     1,950          16,582
  Operating Expenses                     327         566       1,061     1,358           3,871
                                   ----------  -----------  --------  ---------    -----------
    Total Expenses                     1,077         566       4,231     3,308          20,453
                                   ----------  -----------  --------  ---------    -----------
    Net loss from Operations          (1,077)       (566)     (4,321)   (3,308)        (20,453)

Provision for Income Taxes:
---------------------------
  Income Tax Benefit                     -            -          -          -                -
    Net Income (Loss)              $  (1,077)   $   (566)    $(4,321) $ (3,308)    $   (20,453)
                                   ==========   ==========  ========  =========    ===========
Basic and Diluted Earnings
Per Common                         $  (0.000)    $(0.000)   $(0.001)  $ (0.001)    $    (0.005)
                                   ==========   ==========  ========  =========    ===========
Weighted Average number of Common
used in per share calculations     4,000,000    4,000,000  4,000,000  4,000,000      4,000,000
share calculations                 ==========   ========== =========  =========    ===========

</TABLE>




               See accompanying notes to Financial Statements.

                                       5


<PAGE>

<TABLE><CAPTION>
                              DrGoodTeeth.Com
                     (A Development Stage Enterprise)
                         Statement of Cash Flows
                                (Unaudited)

                                      Nine Months Ended
                                         September 30          -----------------
                                   --------------------------  From Inception to
                                      2002            2001     September 30,2002
                                   ------------  -------------------------------
<S>                                    <C>            <C>               <C>

Cash Flows from Operating Activities:
-------------------------------------
  Net Income (Loss)                 $     (4,321)   $   (3,308)    $    (20,453)
  Accounts Payable                             -             -               -
                                    -------------  -----------------------------
Net Cash Provided from
Operating Activities                $     (4,321)   $   (3,308)    $    (20,453)
                                    -------------  -----------------------------

Cash Flows from Investing Activities:
-------------------------------------
  Other Assets                                 -              -               -
                                    -------------  -----------------------------
Net Cash Used in                                -              -               -
Investing Activities                -------------  -----------------------------


Cash Flows from Financing Activities:
-------------------------------------
  Common Stock                                 -              -        105,000
                                     ------------   ----------------------------
Net Cash Provided from                         -              -        105,000
Financing Activities                 -------------  ----------------------------
Net Increase in Cash                      (4,321)       (3,308)         85,547
                                      ------------   ---------------------------
Cash Balance, Begin Period                88,868        92,875              -
                                      ------------   ---------------------------
Cash Balance, End Period               $  85,547    $   89,567    $    85,547
                                      =============  ===========================
Supplemental Disclosures:
  Cash Paid for interest               $          -   $         -     $        -
                                      =============  ===========================
  Cash Paid for income taxes           $          -   $         -     $        -
                                      =============  ===========================
</TABLE>
               See accompanying notes to Financial Statements.

                                         6
<PAGE>


                           DrGoodTeeth.Com
                    Notes to Financial Statements
                       September 30, 2002 and 2001
                             (Unaudited)

NOTE 1  -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization
------------
DrGoodTeeth.Com ("the Company") was incorporated under the laws of the State
of Nevada on February 15, 2000 for the purpose to promote and carry on any
lawful business for which a corporation may be incorporated under the laws of
the State of Nevada. The company has a total of 100,000,000 authorized shares
with a par value of $.001 per share and with 4,000,000 shares issued and
outstanding as of September 30, 2002. The Company has been inactive since
inception and has little or no operating revenues or expenses.

Development Stage Enterprise
----------------------------
The Company is a development stage enterprise, as defined in Financial
Accounting Standards Board No. 7. The Company is devoting all of its present
efforts in securing and establishing a new business, and its planned
principal operations have not commenced, and, accordingly, no revenue has
been derived during the organizational period.

Note 2 - Basis of Presentation
------------------------------
The unaudited financial statements included herein have been prepared
in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10QSB and Item
301(b) of Regulation SB.  Accordingly, they do not include all of the
information and footnotes required by generally accepted accounting
principles for complete financial statements.  In the opinion of
management, all adjustments (consisting of normal recurring accruals)
considered necessary for a fair presentation have been included.
Operating results for the three months ended September 30, 2002 and 2001
and from inception (February 15, 2000) to September 30, 2002 are not
necessarily indicative of the results that may be expected for the
year ended December 31, 2002.  The September 30, 2002 balance sheet was
derived from audited financial statements, but does not include all
disclosures required by generally accepted accounting principles.
Certain information and note disclosures normally included in
financial statements prepared in accordance with generally accepted
accounting principles have been condensed or omitted pursuant to
such rules and regulations relating to interim financial
statements.  For further information, the statements should be read
in conjunction with the audited financial statements and notes
thereto included in the Company's registration statement on Form 10-
KSB, as amended.

Startup and organization costs are recorded in accordance with the
provisions of Statement of Position 98-5 "Reporting Costs of Start-
up Activities" (SO 98-5).  SOP 98-5 requires that the costs of
start-up activities, including organization costs, be expensed as
incurred.
                              7
<PAGE>

                            DrGoodTeeth.Com
                    Notes to Financial Statements
                       September 30, 2002 and 2001
                             (Unaudited)

Note 2 - Basis of Presentation (cont'd)
---------------------------------------
The Company adopted Financial Accounting Standards (SFAS) No. 128,
"Earnings Per Share", which simplifies the computation of earnings
per share requiring the restatement of all prior periods.  Basic
earnings per share are computed on the basis of the weighted average
number of common shares outstanding during each year.  Diluted
earnings per share are computed on the basis of the weighted average
number of common shares and dilutive securities outstanding.
Dilutive securities having an anti-dilutive effect on diluted
earnings on diluted earnings per share are excluded from the
calculation.

Note 3 - Commitments and Contingencies
--------------------------------------
The Company, from time to time, may be subject to legal proceedings
and claims that arise in the ordinary course of its business.
Currently, the Company is not subject to any legal proceedings or
other claims.


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

Results of Operations
---------------------
Registrant has not yet commenced full business operations and has not
yet realized any revenues for the period from inception to the nine
months ended September 30, 2002.

Registrant had a net loss of $4,321 and $3,308, respectively, for the
mine months ended September 30, 2002 and 2001, resulting in a net loss
per share of $0.001 for the nine months ended September 30, 2002 and
2001.

General and administrative expenses for the nine month period ended
September 30, 2002 and 2001 were $4,321 and $3,308, respectively,
of which $3,261 and $1950, respectively, were professional fees and
$1,061 and $1,358, respectively, were operating expenses.


                              8
<PAGE>



Liquidity and Capital Resources
-------------------------------
At the nine months ended September 30, 2002, Registrant's primary source
of liquidity included cash and cash equivalents of $84,547. Cash in
the bank at the nine months ended September 30, 2002 was the balance of
proceeds raised in Registrant's initial public offering conducted in
the State of Nevada, pursuant to Rule 504 of Regulation D.

Registrant believes that its existing cash balance and future operating
cash flows will be sufficient for near term operating needs. The extent
to which such sources will be sufficient to meet Registrant's
anticipated cash requirements is subject to a number of uncertainties,
the most important of which is Registrant's ability  to generate
sufficient cash flow to support its proposed business operations.

   	              PART II - OTHER INFORMATION
                      ---------------------------

ITEM 6.	EXHIBITS AND REPORTS OF FORM 8-K

A) The following exhibits marked with an asterisk and required to be
filed herein are incorporated by reference to Registrant's Form 10-SB,
previously filed with the Commission on September 18, 2000 under SEC
File No. 000-31547.

B)  There were no reports on Form 8-K filed during the quarter.


                         SIGNATURES
                         ----------
In accordance with the requirements of the Exchange Act, the
registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


                             DrGoodTeeth.com, a Nevada corporation

Dated: November 3, 2002      By:/s/ Dr. Anchana Chayawatana,
                             President, CEO and Chairman of the
                             Board of Directors

Dated: November 3, 2002      By:/s/ Lt.Dr. Somdul Manpiankarn,
                             Treasurer, CFO and Director

Dated: November 3, 2002      By:/s/ Dr. Bancha Luengaram, Vice-
                             President of Marketing and Director



                                9
<PAGE>

CERTIFICATION PURSUANT TO SECTION 302 of the SARBANES-OXLEY ACT OF 2002
-----------------------------------------------------------------------

   I, Anchana Chayawatana, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of DrGoodTeeth.
com.

2. Based on my knowledge, this quarterly report does not contain any
untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect
to the period covered by this quarterly report.

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all
material respects the financial condition, results of operations and
cash flows of DrGoodTeeth.com as of, and for, the periods
presented in this quarterly report.

4.  DrGoodTeeth.com's other certifying officers and I are
responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for
Natalma Industries, Inc. and have:

     (a) designed such disclosure controls and procedures to
     ensure that material information relating to DrGoodTeeth.com,
     including its consolidated subsidiaries, is made known to us
     by others within those entities, particularly during the period
     in which this quarterly report is being prepared;

     (b) evaluated the effectiveness of DrGoodTeeth.com's
     disclosure controls and procedures as of a date within
     90 days prior to the filing date of this quarterly report
     (the "Evaluation Date"); and

     (c) presented in this quarterly report our conclusions
     about the effectiveness of the disclosure controls and
     procedures based on our evaluation as of the Evaluation Date;

5.  The other certifying officers and I have disclosed, based on our
most recent evaluation, to our auditors and the audit committee of our
Board of Directors (or persons performing the equivalent functions):

   (a)	all significant deficiencies in the design or operation of
   internal controls which could adversely affect our ability to
   record, process, summarize and report financial data and have
   identified for our auditors any material weaknesses in internal
   controls; and

   (b)	any fraud, whether or not material, that involves management
   or other employees who have a significant role in our internal
   controls.

6. The other certifying officers and I have indicated in this quarterly
report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal
controls subsequent to the date of our most recent evaluation,
including any corrective actions with regard to significant deficiencies
and material weaknesses.

	November 3, 2002      /s/ Anchana Chayawatana
                              ----------------------------------------
			      Anchana Chayawatana, Chief Executive
                              Officer and Chairman of the Board of
                              Directors

    			       10
<PAGE>